← Eichor
Study identifier: NCT06773650 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Proper Dietary Management, Follow-up, and Lactase Enzyme Supplementation for Lactose Intolerance

Condition: Lactose Intolerant · Lactose Malabsorption · Lactose Intolerance  ·  Sponsor: European Institute of Oncology

PhaseN/A
Planned participants385
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Lactose intolerance (LI) is considered the clinical syndrome caused by lactose malabsorption (LM). It is possible to identify four causes of lactase deficiency defining four different types of LM: primary (genetic), secondary (acquired), congenital (alactasia), and developmental (in premature infants, so reversible). The aim of this protocol is to investigate through an anonymous online survey the knowledge of the Italian population on clinical, pathophysiological, diagnostic and therapeutic issues of lactose intolerance. Data collected will be divulgated through a publication for both people with IL and nutritionists, enriched with tables and flow charts, to improve the knowledge on lactose intolerance and to support people suffering from this condition. The results of this survey will guide subjects suspected of suffering from lactose intolerance towards a correct diagnosis and a better management.

This description comes directly from the study's public registry record.

Talk to the study team

Patrizia Gnagnarella  ·  +390257489823  ·  patrizia.gnagnarella@ieo.it

Always discuss trial participation with your own doctor first.

Locations (1)

European Institute of OncologyMilan, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06773650